How have MLTX and PRCT total returns compared?

Over the past 5 years, MLTX delivered 2.81% and PRCT delivered -14.36% annualized total return. Past performance doesn't predict future results.

MoonLake Immunotherapeutics (MLTX) vs PROCEPT BioRobotics Corporation (PRCT)

A side-by-side comparison of MoonLake Immunotherapeutics and PROCEPT BioRobotics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MLTX

MoonLake Immunotherapeutics

$921M

$10.95HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

PRCT

PROCEPT BioRobotics Corporation

$997M

$17.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — MLTX vs PRCT

growth of $100 · dividends reinvested · last 5y

MLTX +14.9% (+2.8%/yr)PRCT -57.5% (-15.7%/yr)MLTX compounded faster over this window

MLTX PRCT

MLTX vs PRCT: by the numbers

•PRCT is the larger company ($997M vs $921M market cap).
•Both run net losses; MLTX's is the smaller (0.00% vs -32.54% net margin).

Metrics side by side

Valuation

Metric	MLTX	PRCT
P/S ratio	N/A	2.95
P/B ratio	2.15	2.93

Profitability

Metric	MLTX	PRCT
Gross margin	0.00%	63.74%
Operating margin	0.00%	-33.86%
Net margin	0.00%	-32.54%
ROE	-61.58%	-32.27%
ROIC	-50.77%	-27.51%

Growth (annualized)

Metric	MLTX	PRCT
Revenue CAGR (5Y)	N/A	74.27%
Total return CAGR (5Y)	2.81%	-14.36%

Frequently asked

How have MLTX and PRCT total returns compared?: Over the past 5 years, MLTX delivered 2.81% and PRCT delivered -14.36% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MLTX analysis Full PRCT analysis Interactive comparison tool

Dig into the metrics

MoonLake Immunotherapeutics ROE PROCEPT BioRobotics ROE MoonLake Immunotherapeutics operating margin PROCEPT BioRobotics operating margin MoonLake Immunotherapeutics revenue growth PROCEPT BioRobotics revenue growth MoonLake Immunotherapeutics free cash flow PROCEPT BioRobotics free cash flow

MoonLake Immunotherapeutics & PROCEPT BioRobotics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.